|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Cardiology (Drs. Yip, Wu, Wang, Cheng, Chua, and Chen), Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Republic of China; and the Department of Biological Sciences (Dr. Chang), National Sun Yat-Sen University, Kaohsiung, Taiwan, Republic of China
Correspondence to: Mien-Cheng Chen, MD, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung 123, Ta Pei Rd, Niao Sung Hsiang, Kaohsiung Hsien, 83301, Taiwan, Republic of China; e-mail: chenmien{at}kinghenry.com.tw
| Abstract |
|---|
|
|
|---|
Methods and results: Between May 1993 and July 2002, a total of 1,250 patients with AMI underwent d-PCI in our hospital. Of these 1,250 patients studied, 12 patients (0.96%) had cardiac rupture (ventricular septal defect [VSD], three patients; left ventricular [LV] free wall rupture, nine patients] after d-PCI, with a mean (± SD) time of occurrence of 52.3 ± 36.2 h. Three patients with VSD had an insidious presentation, and two of these patients (66.6%) survived after surgical intervention. However, nine patients with LV free wall rupture always presented with sudden and unanticipated hemodynamic collapse. Cardiopulmonary resuscitation was uniformly unsuccessful in patients with LV free wall rupture, and all patients died as a result of this complication within minutes of its onset. The 30-day mortality rate was significantly higher in patients with cardiac rupture than in patients without this complication (83.3% vs 8.2%, respectively; p < 0.001). Univariate analysis demonstrated that the left anterior descending artery was the most likely to be totally occluded in patients who had developed cardiac rupture (100% vs 66.4%, respectively; p = 0.033). Multiple stepwise logistic regression analysis demonstrated that the most significant factors associated with cardiac rupture were advanced age, female gender, and lower body mass index (BMI; all p < 0.05), whereas early reperfusion with d-PCI was an independent determinant of preventing this complication (p < 0.0001).
Conclusion: Compared with the prethrombolytic era, our study showed that d-PCI had a favorable impact on reducing the incidence of cardiac rupture after AMI. Old age, female gender, lower BMI, and longer time to reperfusion carried a substantially increased risk of cardiac rupture after patients experienced AMIs. Early successful d-PCI was the most powerful determinant of the avoidance of this catastrophic complication after AMI.
Key Words: acute myocardial infarction cardiac rupture direct percutaneous coronary intervention
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Procedure and Protocol
The procedure and protocol have been described previously in detail.13
14
Before stents were available in our country, primary balloon angioplasty was performed in these patients, however, after stents were available in our country, stent implantation was strongly encouraged unless the infarct-related artery (IRA) had heavy calcification, a reference lumen diameter of < 2.5 mm, or a stent-like formation on the treatment site after coronary angioplasty. Left ventriculograms, which were immediately performed after angioplasty, were recorded for 30° right anterior oblique and 60° left anterior oblique views. Echocardiography was routinely performed in each patient either before or after d-PCI.
Platelet glycoprotein IIb/IIIa receptor antagonists have been available in our country since August 2000. In our hospital, all patients with AMIs are considered eligible for therapy with glycoprotein IIb/IIIa on presentation in the emergency department after informed consent is obtained, unless there are contraindications. As a result of our government medical insurance policy, only 8 patients (including 1 patient with LV free wall rupture) received abciximab therapy (a loading dose of 0.25 mg/kg body weight, followed by a maintenance infusion of 0.1 mg/min for 18 to 24 h), and 300 patients (including 2 patients with LV free wall rupture) received tirofiban therapy (a loading dose of 20 µg/kg body weight, followed by a maintenance infusion of 0.15 µg/min for 18 to 24 h). Continuous heparin infusion for a further 24 to 48 h was administered only to patients who received balloon angioplasty. Patients were treated with ticlopidine for 2 weeks if stenting was performed. Aspirin (100 mg po once a day) was administered to each patient indefinitely. All other medications, including nitrates, beta-blockers, diuretics, and angiotensin-converting enzyme inhibitors were used as needed in both groups.
Definitions
AMI was defined as the following: (1) typical chest pain lasting for > 30 min with ST-segment elevation of > 1 mm in two consecutive precordial or inferior leads and (2) typical chest pain lasting for > 30 min with a new onset of complete left bundle branch block. Procedural success was defined as a reduction in residual stenosis of < 50% by balloon angioplasty or successful stent deployment at the desired position with a residual stenosis of < 20% followed by Thrombolysis in Myocardial Infarction (TIMI)15
grade 3 flow in the IRA. Body mass index (BMI) was defined as the weight (in kilograms) divided by the square of the height (in meters). VSD was first suspected by physical examination and subsequently was confirmed by echocardiography, a significant step-up in oxygen saturation between the right atrium and the pulmonary artery using a Swan-Ganz catheter, and operative findings. LV free wall rupture was suspected by a patients sudden hemodynamic collapse associated with the patients loss of consciousness and electromechanical dissociation without ECG evidence of malignant ventricular tachyarrhythmias. A diagnosis subsequently was made by echocardiographic findings of a new accumulated pericardial effusion and further was confirmed by pericardiocentesis via an apical approach method.
Data Collection
Detailed in-hospital and follow-up data including age, sex, coronary risk factors, Killip score on hospital admission, reperfusion time, pre-TIMI and post-TIMI flow grades, angiographic results, number of diseased vessels and coronary aneurysms, and number of in-hospital adverse events were obtained. These data were collected prospectively and were entered into a computerized database.
Statistical Analysis
Data were expressed as the mean ± SD. Continuous variables were compared using the Wilcoxon rank sum test. Categoric variables were compared using the
2 test or Fischer exact test. Stepwise logistic regression analysis was used to determine the independent determinants of cardiac ruptures after d-PCI. Statistical analysis was performed using a statistical software package (SAS for Windows, version 6.12; SAS Institute; Cary, NC). A probability value of < 0.05 was considered to be statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Timing and Possible Mechanisms of Cardiac Rupture in the d-PCI Reperfusion Era
It has been stated7
8
that the peak incidence of cardiac rupture occurs 5 to 7 days after infarction in the prethrombolytic therapy era. To the contrary, most cardiac ruptures that are associated with early thrombolytic therapy occur within 24 h after treatment.2
12
16
These large clinical trials2
12
16
also have demonstrated that although the frequency of cardiac rupture decreases, early thrombolytic therapy (ie, within 6 h) paradoxically accelerates the timing of this complication, and late thrombolytic therapy has been found to increase the risk of cardiac rupture.11
Several possible mechanisms, including extension of myocardial hemorrhage weakening and dissection of the necrotizing zone,12
16
diminishing of the myocardial collagen content,17
and digestion of collagen by collagenases18
19
and plasmin,20
have been suggested.
In the present study, several important observations were made. First, the timing of cardiac rupture in our patients varied (range, 4.8 h to 5 days) with a mean time of 52.3 h. The mean time of occurrence of this complication in our patients was earlier than that in the prethrombolytic therapy era7 8 but was later than that in the thrombolytic therapy era,2 16 which suggests that reperfusion therapy by d-PCI does not accelerate the timing of cardiac rupture, as occurred with thrombolytic therapy.2 12 16 Second, our patients with cardiac rupture had significantly longer time to reperfusion than did those without cardiac rupture. This finding suggests that the risk of cardiac rupture after AMI is related directly to the timing of reperfusion. Third, angiographic findings demonstrated that the incidence of a totally occluded left anterior descending artery was significantly higher in patients with cardiac rupture than in patients without it. This finding suggests that a transmural myocardial infarction is more likely to occur in these patients.
Relationships Among Age, Gender, BMI, and Cardiac Rupture
Advanced age has been found to be an increased risk factor for adverse outcomes after AMI.21
The risks increased proportionally with advancing age, and primary angioplasty did not alter the relationship between adverse outcomes after AMI and being aged.21
The contributing factors to this relationship included the presence of additional comorbid conditions, more advanced multivessel disease, and a longer time between the onset of symptoms and presentation for evaluation and treatment.21
22
23
In the present study, old age was an independent predictor of cardiac rupture. Our finding confirmed the strong relationship between advanced age and increased adverse outcomes in the clinical setting of AMI.
Morbidity and mortality after AMI have been reported to be higher in women than in men.24 In the present study, we also found that female gender was another independent predictor of cardiac rupture. In the present study, it is interesting to note that women constituted only 16.2% of our patient population. However, it is surprising that > 66% of patients with cardiac rupture were women. We remain uncertain why women are more likely to experience cardiac rupture after AMI. However, this may be due to older age in female patients and to other fundamental differences in the biology and pathophysiology of AMI between men and women.24
In patients with coronary artery disease who are undergoing PCI, lean patients recently have been reported25 to be at increased risk for in-hospital complications and cardiac death. However, the mechanism by which lean patients have an excess risk for these complications remains unclear.25 In the present study, we also found that patients with cardiac rupture had significantly lower BMI values than those without this complication. Furthermore, multiple stepwise logistic regression analysis demonstrated that BMI was an independent predictor of cardiac rupture. This may reflex a synergic effect of being female and lean body weight on the predilection of cardiac rupture after AMI.
Formidable Challenges for Management of Cardiac Rupture
It is estimated that 8 to 17% of all fatal myocardial infarctions are the result of myocardial rupture.26
Despite improvements in medical therapy and in percutaneous and surgical techniques, mortality from this complication remains extremely high.2
These patients usually die immediately, even before a diagnosis can be confirmed.4
In the present study, we found that the mortality rate caused by cardiac rupture was 8.9% (10 of 112 patients) of all fatal myocardial infarctions in our patient population. Our finding is consistent with previous observations.12
26
The overall mortality rate was very high (83.3%) in patients with cardiac rupture. It was disappointing that all of our patients with LV free wall rupture died despite heroic therapeutic bedside management. The primary obstacle in preventing death from LV free wall rupture is the extremely limited time in which surgery can be initiated, as the occurrence of LV free wall rupture is sudden and unanticipated without a constellation of signs or symptoms to indicate impending rupture in these patients, and it is followed by rapid hemodynamic deterioration.
There are several limitations to this study. First, the number of patients with cardiac rupture in this study was small, therefore, our results should be viewed as preliminary and need to await confirmation by larger clinical trials. Second, cardiac rupture, pseudoaneurysm, or incomplete rupture could easily be missed since premortem echocardiograms were often unavailable and cultural factors prevent postmortem examination. Therefore, the incidences of these complications could have been underestimated in our study. Third, as the number of patients with cardiac rupture was small in this study, the lack of significant differences in the incidences of previous myocardial infarction, anterior wall infarction, preinfarction angina, presence of collateral circulation, pre-TIMI flow, and method of reperfusion between patients with cardiac rupture and without could have been due to a type-2 error.
In conclusion, advanced age, female gender, a lower BMI, and longer time to reperfusion were significant independent predictors of cardiac rupture after AMI, and d-PCI had a favorable impact on reducing the incidence of cardiac rupture. Early successful d-PCI was the most significant independent determinant for preventing this catastrophic complication after AMI.
| Footnotes |
|---|
Received for publication August 27, 2002. Accepted for publication December 12, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Weissman, C. C. Kwon, R. K. Shaw, and J. F. Setaro Free-Wall Rupture of the Myocardium Following Infarction: A Changing Clinical Portrait in the Reperfusion Era: A Case Report Angiology, October 1, 2006; 57(5): 636 - 642. [Abstract] [PDF] |
||||
![]() |
F. Formica, F. Corti, L. Avalli, and G. Paolini ECMO support for the treatment of cardiogenic shock due to left ventricular free wall rupture Interactive CardioVascular and Thoracic Surgery, February 1, 2005; 4(1): 30 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Keeley and C. L. Grines Primary Percutaneous Coronary Intervention for Every Patient with ST-Segment Elevation Myocardial Infarction: What Stands in the Way? Ann Intern Med, August 17, 2004; 141(4): 298 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Yip, C.-Y. Fang, K.-T. Tsai, H.-W. Chang, K.-H. Yeh, M. Fu, and C.-J. Wu The Potential Impact of Primary Percutaneous Coronary Intervention on Ventricular Septal Rupture Complicating Acute Myocardial Infarction Chest, May 1, 2004; 125(5): 1622 - 1628. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |